Similarly, cleavage and polyadenylation‐specific factor 6 (CPSF6) stabilizes c‐Myc through nuclear colocalization,77 while its depletion promotes c‐Myc degradation, inhibits glycolysis, and sensitizes HCC to sorafenib. Here, MYC is linked to hepatocellular carcinoma.